Establishing normal reference ranges for PSA change with age in a population‐based study: The Krimpen study

We aim to establish the normal pattern of prostate specific antigen (PSA) change with age to provide a baseline from which disease progression might be identified in prostate cancer patients included in active surveillance programs.

[1]  M. Cooperberg,et al.  Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE. , 2003, The Journal of urology.

[2]  Siep Thomas,et al.  Prostate Cancer Detection in Older Men with and without Lower Urinary Tract Symptoms: A Population‐Based Study , 2003, Journal of the American Geriatrics Society.

[3]  J. Anderson,et al.  Age-specific reference ranges for serum prostate-specific antigen. , 1995, Urology.

[4]  G. Duncan,et al.  Watchful waiting or watchful progression? , 1998, Cancer.

[5]  J A Hanley,et al.  Screening for prostate cancer: estimating the magnitude of overdetection. , 1998, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[6]  Jerome P. Richie,et al.  Diagnosis and Staging of Prostate Cancer , 2003 .

[7]  D. Chan,et al.  Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease. , 1992, Cancer research.

[8]  J. Sterne,et al.  A New Method for Predicting Recovery After Stroke , 2001, Stroke.

[9]  J. Sterne,et al.  Multilevel growth curve models with covariate effects: application to recovery after stroke , 2001, Statistics in medicine.

[10]  L. Bégin,et al.  Utility of PSA doubling time in follow-up of untreated patients with localized prostate cancer. , 2002, Urology.

[11]  E. Rakovitch,et al.  PSA doubling time of prostate carcinoma managed with watchful observation alone. , 2001, International journal of radiation oncology, biology, physics.

[12]  J. Bosch,et al.  Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status , 2000, BJU international.

[13]  B. G. Blijenberg,et al.  Different PSA assays lead to detection of prostate cancers with identical histological features. , 2002, European urology.

[14]  W. Hop,et al.  Parameters of prostate volume and shape in a community based population of men 55 to 74 years old. , 1994, The Journal of urology.

[15]  J. Bosch,et al.  Loss to Follow-Up in a Longitudinal Study on Urogenital Tract Symptoms in Dutch Older Men , 2005, Urologia Internationalis.

[16]  G. Duncan,et al.  Watchful waiting or watchful progression? , 1998, Cancer.

[17]  C. Bangma,et al.  Watchful waiting in prostate cancer: review and policy proposals , 2003, BJU international.

[18]  C G Chute,et al.  Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. , 1993, JAMA.

[19]  D. Neal,et al.  Screening for prostate cancer , 2003, The Lancet.

[20]  Michael J Barry,et al.  Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut , 2002, BMJ : British Medical Journal.

[21]  J. Lindsey.  Models for Repeated Measurements , 1993 .

[22]  J. Bosch,et al.  Prostate specific antigen in a community‐based sample of men without prostate cancer: Correlations with prostate volume, age, body mass index, and symptoms of prostatism , 1995, The Prostate.

[23]  Jenny Donovan,et al.  Quality improvement report , 2002, BMJ : British Medical Journal.

[24]  Harry J de Koning,et al.  Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. , 2003, Journal of the National Cancer Institute.

[25]  Peter H Gann,et al.  Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. , 2002, Journal of the National Cancer Institute.

[26]  W. Kirkels,et al.  The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study. , 1999, The Journal of urology.